Bicara Therapeutics Inc (BCAX)

Bicara Therapeutics Inc. experienced eleven insider transactions over the past ninety days, all involving sales totaling approximately 3.8 million dollars. These divestments occurred amid a 68.8% decline in stock value. Following the August 2026 results financiers, leadership including the CEO and CFO executed planned or proposed disposals of their equity holdings.
Ticker: BCAX Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bicara Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
DAVID RABEN Officer Officer
Transaction date
Proposed sale
Price
23.02
Quantity 72,471
Value US$4,673,716
Cohlhepp Ryan President, COO & Interim CEO Executive Director
Transaction date
Planned sale
Price
57.44
Quantity 24,143 +47.7%
Value US$2,384,697
Cohlhepp Ryan President, COO & Interim CEO Executive Director
Transaction date
Planned sale
Price
59.67
Quantity 37,618 -43.2%
Value US$1,029,947
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
22.64
Quantity 12,500
Value US$283,000
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
22.64
Quantity 17,500
Value US$396,200
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.97
Quantity 12,500 -8.8%
Value US$349,591
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
27.98
Quantity 18,750 -9.4%
Value US$524,533
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.98
Quantity 10,000 -2.7%
Value US$279,750
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
27.83
Quantity 12,500
Value US$347,875
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.83
Quantity 18,750
Value US$521,812
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.83
Quantity 10,000
Value US$278,300
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.68
Quantity 28 -0.0%
Value US$831
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.42
Quantity 9,972 -2.7%
Value US$283,367
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
29.68
Quantity 10,000
Value US$296,800
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
29.00
Quantity 536 -0.3%
Value US$15,544
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
30.35
Quantity 1,075 -0.6%
Value US$32,632
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
29.80
Quantity 4,306 -2.3%
Value US$128,302
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
28.76
Quantity 22,833 -10.9%
Value US$656,652
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
30.31
Quantity 830 -0.6%
Value US$25,160
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
29.82
Quantity 4,413 -3.3%
Value US$131,616
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
28.60
Quantity 22,757 -14.4%
Value US$650,896
DAVID RABEN Officer Officer
Transaction date
Proposed sale
Price
28.56
Quantity 50,000
Value US$1,428,080
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
30.25
Quantity 28,750
Value US$869,688
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
30.25
Quantity 28,000
Value US$847,000
3.5
Lara Meisner Officer Officer
Transaction date
Proposed sale
Price
29.77
Quantity 1,000
Value US$29,774
DAVID RABEN Officer Officer
Transaction date
Proposed sale
Price
26.49
Quantity 50,000
Value US$1,324,650
3.5
Meisner Lara Former Chief Legal Officer Officer
Transaction date
Proposed sale
Price
20.64
Quantity 71,390
Value US$1,473,716
Raben David Officer Officer
Transaction date
Proposed sale
Price
21.82
Quantity 5,500
Value US$120,010
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
20.42
Quantity 9,200 -6.0%
Value US$187,883
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
20.42
Quantity 9,200
Value US$187,883
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
20.35
Quantity 2,978 -0.8%
Value US$60,597
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
19.96
Quantity 12,022 -3.2%
Value US$239,982
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.92
Quantity 15,000
Value US$313,800
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.92
Quantity 15,000
Value US$313,800
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
20.29
Quantity 4,500 -2.3%
Value US$91,314
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
20.29
Quantity 8,000 -3.9%
Value US$162,335
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.31
Quantity 12,500
Value US$253,875
Raben David Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.88
Quantity 5,500 -9.0%
Value US$125,830
Raben David Officer Officer
Transaction date
Proposed sale
Price
22.88
Quantity 5,500
Value US$125,830
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
23.00
Quantity 9,200 -6.0%
Value US$211,614
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
23.18
Quantity 9,200
Value US$213,210
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
23.61
Quantity 15,000 -4.0%
Value US$354,146
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
23.74
Quantity 15,000
Value US$356,100
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
23.01
Quantity 4,500 -2.2%
Value US$103,533
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
23.01
Quantity 8,000 -3.8%
Value US$184,058
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
22.98
Quantity 12,500
Value US$287,250
Raben David Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.95
Quantity 5,500 -9.0%
Value US$104,229
Raben David Officer Officer
Transaction date
Proposed sale
Price
18.95
Quantity 5,500
Value US$104,229
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.52
Quantity 9,200 -6.0%
Value US$170,348
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
18.60
Quantity 9,200
Value US$171,120
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.95
Quantity 1,596 -0.5%
Value US$30,246
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
18.95
Quantity 1,596
Value US$30,246
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.78
Quantity 6,905 -2.0%
Value US$129,705
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
18.78
Quantity 6,905
Value US$129,705
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.84
Quantity 6,499 -1.9%
Value US$122,415
Mazumdar Claire Officer; Director Executive Director
Transaction date
Proposed sale
Price
19.19
Quantity 6,499
Value US$124,716
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
19.66
Quantity 4,500 -2.2%
Value US$88,457
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
19.66
Quantity 8,000 -3.8%
Value US$157,257
Cohlhepp Ryan Officer; Director Executive Director
Transaction date
Proposed sale
Price
19.34
Quantity 12,500
Value US$241,750
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
19.17
Quantity 36,766 -9.8%
Value US$704,657
Mazumdar Claire Officer Officer
Transaction date
Proposed sale
Price
19.17
Quantity 36,766
Value US$704,657
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.75
Quantity 3,817 -1.1%
Value US$71,572
Mazumdar Claire Officer Officer
Transaction date
Proposed sale
Price
19.80
Quantity 3,817
Value US$75,572
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.74
Quantity 1,786 -0.5%
Value US$33,464
Mazumdar Claire Officer Officer
Transaction date
Proposed sale
Price
18.74
Quantity 1,786
Value US$33,464
Mazumdar Claire Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.73
Quantity 2,631 -0.8%
Value US$49,289
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.25
Quantity 2,963 -2.0%
Value US$54,062
Raben David Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.52
Quantity 16,300 -22.8%
Value US$301,920
Hyep Ivan Officer Officer
Transaction date
Proposed sale
Price
18.25
Quantity 2,963
Value US$54,062
Mazumdar Claire Officer Officer
Transaction date
Proposed sale
Price
18.73
Quantity 2,631
Value US$49,289
Raben David Officer Officer
Transaction date
Proposed sale
Price
18.52
Quantity 16,300
Value US$301,920
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
18.16
Quantity 4,500 -2.1%
Value US$81,734
Cohlhepp Ryan President and COO Executive Director
Transaction date
Planned sale
Price
18.16
Quantity 12,892 -5.8%
Value US$234,159
Hyep Ivan Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.22
Quantity 13,555 -8.5%
Value US$246,910
Raben David Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.45
Quantity 200 -0.4%
Value US$3,690
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-21 2026-10-21 PrS Proposed sale

Officer

Officer
72,471
23.02
US$4,673,716
72,471 23.02 US$4,673,716
2026-09-10 2026-09-08 PlS Planned sale

President, COO & Interim CEO

Executive Director
24,143 +47.7%
57.44
US$2,384,697
24,143 +47.7% 57.44 US$2,384,697
2026-09-10 2026-09-08 PlS Planned sale

President, COO & Interim CEO

Executive Director
37,618 -43.2%
59.67
US$1,029,947
37,618 -43.2% 59.67 US$1,029,947
2026-09-08 2026-09-08 PrS Proposed sale

Officer

Officer
12,500
22.64
US$283,000
12,500 22.64 US$283,000
2026-09-08 2026-09-08 PrS Proposed sale

Officer; Director

Executive Director
17,500
22.64
US$396,200
17,500 22.64 US$396,200
2026-08-12 2026-08-10 PlS Planned sale

Chief Financial Officer

Officer
12,500 -8.8%
27.97
US$349,591
12,500 -8.8% 27.97 US$349,591
2026-08-12 2026-08-10 PlS Planned sale

President and COO

Executive Director
18,750 -9.4%
27.98
US$524,533
18,750 -9.4% 27.98 US$524,533
2026-08-12 2026-08-10 PlS Planned sale

Chief Executive Officer

Executive Director
10,000 -2.7%
27.98
US$279,750
10,000 -2.7% 27.98 US$279,750
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
12,500
27.83
US$347,875
12,500 27.83 US$347,875
2026-08-10 2026-08-10 PrS Proposed sale

Officer; Director

Executive Director
18,750
27.83
US$521,812
18,750 27.83 US$521,812
2026-08-10 2026-08-10 PrS Proposed sale

Officer; Director

Executive Director
10,000
27.83
US$278,300
10,000 27.83 US$278,300
2026-07-14 2026-07-10 PlS Planned sale

Chief Executive Officer

Executive Director
28 -0.0%
29.68
US$831
28 -0.0% 29.68 US$831
2026-07-14 2026-07-10 PlS Planned sale

Chief Executive Officer

Executive Director
9,972 -2.7%
28.42
US$283,367
9,972 -2.7% 28.42 US$283,367
2026-07-10 2026-07-10 PrS Proposed sale

Officer; Director

Executive Director
10,000
29.68
US$296,800
10,000 29.68 US$296,800
2026-07-10 2026-07-09 PlS Planned sale

President and COO

Executive Director
536 -0.3%
29.00
US$15,544
536 -0.3% 29.00 US$15,544
2026-07-10 2026-07-08 PlS Planned sale

President and COO

Executive Director
1,075 -0.6%
30.35
US$32,632
1,075 -0.6% 30.35 US$32,632
2026-07-10 2026-07-08 PlS Planned sale

President and COO

Executive Director
4,306 -2.3%
29.80
US$128,302
4,306 -2.3% 29.80 US$128,302
2026-07-10 2026-07-08 PlS Planned sale

President and COO

Executive Director
22,833 -10.9%
28.76
US$656,652
22,833 -10.9% 28.76 US$656,652
2026-07-10 2026-07-08 PlS Planned sale

Chief Financial Officer

Officer
830 -0.6%
30.31
US$25,160
830 -0.6% 30.31 US$25,160
2026-07-10 2026-07-08 PlS Planned sale

Chief Financial Officer

Officer
4,413 -3.3%
29.82
US$131,616
4,413 -3.3% 29.82 US$131,616
2026-07-10 2026-07-08 PlS Planned sale

Chief Financial Officer

Officer
22,757 -14.4%
28.60
US$650,896
22,757 -14.4% 28.60 US$650,896
2026-07-08 2026-07-08 PrS Proposed sale

Officer

Officer
50,000
28.56
US$1,428,080
50,000 28.56 US$1,428,080
2026-07-08 2026-07-08 PrS Proposed sale

Officer; Director

Executive Director
28,750
30.25
US$869,688
28,750 30.25 US$869,688
2026-07-08 2026-07-08 PrS Proposed sale

Officer

Officer
28,000
30.25
US$847,000
28,000 30.25 US$847,000
2026-07-07 2026-07-07 PrS Proposed sale

Officer

Officer
1,000
29.77
US$29,774
1,000 29.77 US$29,774
2026-06-25 2026-06-25 PrS Proposed sale

Officer

Officer
50,000
26.49
US$1,324,650
50,000 26.49 US$1,324,650
2026-06-01 2026-06-01 PrS Proposed sale

Former Chief Legal Officer

Officer
71,390
20.64
US$1,473,716
71,390 20.64 US$1,473,716
2026-05-26 2026-05-26 PrS Proposed sale

Officer

Officer
5,500
21.82
US$120,010
5,500 21.82 US$120,010
2026-05-26 2026-05-21 PlS Planned sale

Chief Financial Officer

Officer
9,200 -6.0%
20.42
US$187,883
9,200 -6.0% 20.42 US$187,883
2026-05-21 2026-05-21 PrS Proposed sale

Officer

Officer
9,200
20.42
US$187,883
9,200 20.42 US$187,883
2026-05-20 2026-05-18 PlS Planned sale

Chief Executive Officer

Executive Director
2,978 -0.8%
20.35
US$60,597
2,978 -0.8% 20.35 US$60,597
2026-05-20 2026-05-18 PlS Planned sale

Chief Executive Officer

Executive Director
12,022 -3.2%
19.96
US$239,982
12,022 -3.2% 19.96 US$239,982
2026-05-18 2026-05-18 PrS Proposed sale

Officer; Director

Executive Director
15,000
20.92
US$313,800
15,000 20.92 US$313,800
2026-05-18 2026-05-18 PrS Proposed sale

Officer; Director

Executive Director
15,000
20.92
US$313,800
15,000 20.92 US$313,800
2026-05-18 2026-05-15 PlS Planned sale

President and COO

Executive Director
4,500 -2.3%
20.29
US$91,314
4,500 -2.3% 20.29 US$91,314
2026-05-18 2026-05-15 PlS Planned sale

President and COO

Executive Director
8,000 -3.9%
20.29
US$162,335
8,000 -3.9% 20.29 US$162,335
2026-05-15 2026-05-15 PrS Proposed sale

Officer; Director

Executive Director
12,500
20.31
US$253,875
12,500 20.31 US$253,875
2026-04-28 2026-04-27 PlS Planned sale

Chief Medical Officer

Officer
5,500 -9.0%
22.88
US$125,830
5,500 -9.0% 22.88 US$125,830
2026-04-27 2026-04-27 PrS Proposed sale

Officer

Officer
5,500
22.88
US$125,830
5,500 22.88 US$125,830
2026-04-22 2026-04-21 PlS Planned sale

Chief Financial Officer

Officer
9,200 -6.0%
23.00
US$211,614
9,200 -6.0% 23.00 US$211,614
2026-04-21 2026-04-21 PrS Proposed sale

Officer

Officer
9,200
23.18
US$213,210
9,200 23.18 US$213,210
2026-04-20 2026-04-20 PlS Planned sale

Chief Executive Officer

Executive Director
15,000 -4.0%
23.61
US$354,146
15,000 -4.0% 23.61 US$354,146
2026-04-20 2026-04-20 PrS Proposed sale

Officer; Director

Executive Director
15,000
23.74
US$356,100
15,000 23.74 US$356,100
2026-04-17 2026-04-15 PlS Planned sale

President and COO

Executive Director
4,500 -2.2%
23.01
US$103,533
4,500 -2.2% 23.01 US$103,533
2026-04-17 2026-04-15 PlS Planned sale

President and COO

Executive Director
8,000 -3.8%
23.01
US$184,058
8,000 -3.8% 23.01 US$184,058
2026-04-15 2026-04-15 PrS Proposed sale

Officer; Director

Executive Director
12,500
22.98
US$287,250
12,500 22.98 US$287,250
2026-03-26 2026-03-25 PlS Planned sale

Chief Medical Officer

Officer
5,500 -9.0%
18.95
US$104,229
5,500 -9.0% 18.95 US$104,229
2026-03-25 2026-03-25 PrS Proposed sale

Officer

Officer
5,500
18.95
US$104,229
5,500 18.95 US$104,229
2026-03-24 2026-03-23 PlS Planned sale

Chief Financial Officer

Officer
9,200 -6.0%
18.52
US$170,348
9,200 -6.0% 18.52 US$170,348
2026-03-23 2026-03-23 PrS Proposed sale

Officer

Officer
9,200
18.60
US$171,120
9,200 18.60 US$171,120
2026-03-20 2026-03-20 PlS Planned sale

Chief Executive Officer

Executive Director
1,596 -0.5%
18.95
US$30,246
1,596 -0.5% 18.95 US$30,246
2026-03-20 2026-03-20 PrS Proposed sale

Officer; Director

Executive Director
1,596
18.95
US$30,246
1,596 18.95 US$30,246
2026-03-20 2026-03-19 PlS Planned sale

Chief Executive Officer

Executive Director
6,905 -2.0%
18.78
US$129,705
6,905 -2.0% 18.78 US$129,705
2026-03-19 2026-03-19 PrS Proposed sale

Officer; Director

Executive Director
6,905
18.78
US$129,705
6,905 18.78 US$129,705
2026-03-20 2026-03-18 PlS Planned sale

Chief Executive Officer

Executive Director
6,499 -1.9%
18.84
US$122,415
6,499 -1.9% 18.84 US$122,415
2026-03-18 2026-03-18 PrS Proposed sale

Officer; Director

Executive Director
6,499
19.19
US$124,716
6,499 19.19 US$124,716
2026-03-17 2026-03-16 PlS Planned sale

President and COO

Executive Director
4,500 -2.2%
19.66
US$88,457
4,500 -2.2% 19.66 US$88,457
2026-03-17 2026-03-16 PlS Planned sale

President and COO

Executive Director
8,000 -3.8%
19.66
US$157,257
8,000 -3.8% 19.66 US$157,257
2026-03-16 2026-03-16 PrS Proposed sale

Officer; Director

Executive Director
12,500
19.34
US$241,750
12,500 19.34 US$241,750
2026-03-11 2026-03-09 PlS Planned sale

Chief Executive Officer

Executive Director
36,766 -9.8%
19.17
US$704,657
36,766 -9.8% 19.17 US$704,657
2026-03-09 2026-03-09 PrS Proposed sale

Officer

Officer
36,766
19.17
US$704,657
36,766 19.17 US$704,657
2026-03-06 2026-03-06 PlS Planned sale

Chief Executive Officer

Executive Director
3,817 -1.1%
18.75
US$71,572
3,817 -1.1% 18.75 US$71,572
2026-03-06 2026-03-06 PrS Proposed sale

Officer

Officer
3,817
19.80
US$75,572
3,817 19.80 US$75,572
2026-03-06 2026-03-05 PlS Planned sale

Chief Executive Officer

Executive Director
1,786 -0.5%
18.74
US$33,464
1,786 -0.5% 18.74 US$33,464
2026-03-05 2026-03-05 PrS Proposed sale

Officer

Officer
1,786
18.74
US$33,464
1,786 18.74 US$33,464
2026-03-06 2026-03-04 PlS Planned sale

Chief Executive Officer

Executive Director
2,631 -0.8%
18.73
US$49,289
2,631 -0.8% 18.73 US$49,289
2026-03-05 2026-03-04 PlS Planned sale

Chief Financial Officer

Officer
2,963 -2.0%
18.25
US$54,062
2,963 -2.0% 18.25 US$54,062
2026-03-05 2026-03-04 PlS Planned sale

Chief Medical Officer

Officer
16,300 -22.8%
18.52
US$301,920
16,300 -22.8% 18.52 US$301,920
2026-03-04 2026-03-04 PrS Proposed sale

Officer

Officer
2,963
18.25
US$54,062
2,963 18.25 US$54,062
2026-03-04 2026-03-04 PrS Proposed sale

Officer

Officer
2,631
18.73
US$49,289
2,631 18.73 US$49,289
2026-03-04 2026-03-04 PrS Proposed sale

Officer

Officer
16,300
18.52
US$301,920
16,300 18.52 US$301,920
2026-03-05 2026-03-03 PlS Planned sale

President and COO

Executive Director
4,500 -2.1%
18.16
US$81,734
4,500 -2.1% 18.16 US$81,734
2026-03-05 2026-03-03 PlS Planned sale

President and COO

Executive Director
12,892 -5.8%
18.16
US$234,159
12,892 -5.8% 18.16 US$234,159
2026-03-05 2026-03-03 PlS Planned sale

Chief Financial Officer

Officer
13,555 -8.5%
18.22
US$246,910
13,555 -8.5% 18.22 US$246,910
2026-03-05 2026-03-03 PlS Planned sale

Chief Medical Officer

Officer
200 -0.4%
18.45
US$3,690
200 -0.4% 18.45 US$3,690

See older Bicara Therapeutics Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Bicara Therapeutics Inc history with Plus

Billed monthly · Cancel anytime